Background The global burden of disease attributable to respiratory syncytial virus (RSV)
remains unknown. We aimed to estimate the global incidence of and mortality from episodes of …

Respiratory syncytial virus is the second most common cause of infant mortality and a major
cause of morbidity and mortality in older adults (aged >60 years). Efforts to develop a …

Background Seasonal influenza virus is a common cause of acute lower respiratory
infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated …

Background Influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus
are the most common viruses associated with acute lower respiratory infections in …

Background Respiratory syncytial virus (RSV) infection is an important cause of pneumonia
mortality in young children. However, clinical data for fatal RSV infection are scarce. We …

Background Human coronavirus NL63 (HCoV-NL63) is a globally endemic pathogen
causing mild and severe respiratory tract infections with reinfections occurring repeatedly …

Background. Respiratory syncytial virus (RSV) vaccine development for direct protection of
young infants faces substantial obstacles. Assessing the potential of indirect protection using …

Background The lower than expected COVID-19 morbidity and mortality in Africa has been
attributed to multiple factors, including weak surveillance. This study estimated the burden of …

Human respiratory syncytial virus (RSV) is associated with severe childhood respiratory
infections. A clear description of local RSV molecular epidemiology, evolution, and transmission …

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI)
and hospitalization in infants and children globally. Many observational studies have found …